Browse > Article

Remifentanil Protects Human Keratinocyte Through Autophagic Expression  

Kim, Eok Nyun (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University)
Park, Chang Hoon (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University)
Woo, Mi Na (Department of Dental Anesthesia and Pain Medicine, Pusan National University Dental Hospital)
Yoon, Ji Young (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University)
Park, Bong Soo (Department of Oral Anatomy, School of Dentistry, Pusan National University)
Kim, Yong Ho (Department of Oral Anatomy, School of Dentistry, Pusan National University)
Kim, Cheul Hong (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University)
Publication Information
Journal of The Korean Dental Society of Anesthesiology / v.14, no.2, 2014 , pp. 101-106 More about this Journal
Abstract
Background: Remifentanil, an ultra-short-acting mu-opioid receptor agonist, is unique from other opioids because of its esterase-based metabolism, minimal accumulation, and very rapid onset and offset of clinical action. Remifentanil can prevent the inflammatory response and can suppress inducible nitric oxide synthase expression in a septic mouse model. However, the effects of remifentanil on human keratinocyte and autophagy have yet to be fully elucidated during hypoxia-reoxygenation. Here we investigated whether remifentanil confers protective effect against hypoxia-reoxygenation in human keratinocyte and, if so, whether autophagy mediates this effect. Methods: The human keratinocytes were cultured under 1% oxygen tension. The cells were gassed with 94% $N_2$, and 5% $CO_2$ and incubated for 24 h at $37^{\circ}C$. To determine whether the administration of affects human keratinocytes hypoxia-reoxygenation injury, cells were then exposed to various concentrations of remifentanil (0.01, 0.1, 0.5 and 1 ng/ml) for 2 h. After remifentanil treatment, to simulate reoxygenation and recovery, the cells were reoxygenated for 12 h at $37^{\circ}C$. Control group did not receive remifentanil treatment. Normoxia group did not receive hypoxia and remifentanil treatment for 36 h. 3-MA group was treated 3-methyladenine (3-MA) for 1h before remifentanil treatment. Cell viability was measured using a quantitative colorimetric assay with MTT, showing the mitochondrial activity of living cells. Cells were stained with fluorescence and analyzed with Western blot analysis to find out any relations with activation of autophagy. Results: Prominent accumulation of autophagic specific staining MDC was observed around the nuclei in RPT group HaCaT cells. Similarly, AO staining, red fluorescent spots appeared in RPT group HaCaT cells, while the Normoxia, control and 3-MA groups showed mainly green cytoplasmic fluorescence. We here examined activation of autophagy related protein under H/R-induced cells by Western blotting analysis. Atg5, Beclin-1, LC3-II (microtubule-associated protein 1 light chain 3 form II) and p62 was elevated in RPT group cells. But they were decreased when autophagy was suppressed by 3-MA (Fig. 5). Conclusions: Although the findings of this study are limited to an in vitro interpretation, we suggest that remifentanil may have a beneficial effect in the recovery of wound from hypoxia-reoxygenation injury.
Keywords
Autophagy; Hypoxia; Keratinocyte; Remifentanil;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, et al: Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 2006; 8: 1124-32.   DOI   ScienceOn
2 Diaz-Troya S, Perez-Perez ME, Florencio FJ, Crespo JL: The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy 2008; 4: 851-65.   DOI
3 Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, et al: Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol 2005; 167: 1713-28.   DOI   ScienceOn
4 Kundu M, Lindsten T, Yang CY, Wu J, Zhao F, Zhang J, et al: Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood 2008; 112: 1493-502.   DOI   ScienceOn
5 Schwarten M, Mohrluder J, Ma P, Stoldt M, Thielmann Y, Stangler T, et. al: Nix directly binds to GABARAP: a possible crosstalk between apoptosis and autophagy. Autophagy 2009; 5: 690-8.   DOI
6 Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, et al: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008; 456: 259-63.   DOI   ScienceOn
7 Lippens S, Denecker G, Ovaere P, Vandenabeele P, Declercq W: Death penalty for keratinocytes: apoptosis versus cornification. Cell Death Differ 2005; 12 Suppl 2: 1497-508.   DOI   ScienceOn
8 Coulombe PA: Wound epithelialization: accelerating the pace of discovery. J Invest Dermatol 2003; 121: 219-30.   DOI   ScienceOn
9 Nakatogawa H, Suzuki K, Kamada Y, Ohsumi Y: Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat Rev Mol Cell Biol 2009; 10: 458-67.   DOI   ScienceOn
10 Saitoh T, Fujita N, Jang MH, Uematsu S, Yang BG, Satoh T, et al: Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008; 456: 264-8.   DOI   ScienceOn
11 Barcelos LS, Duplaa C, Krankel N, Graiani G, Invernici G, Katare R, et al: Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 2009; 104: 1095-102.   DOI   ScienceOn
12 Lazarides MK, Giannoukas AD: The role of hemodynamic measurements in the management of venous and ischemic ulcers. Int J Low Extrem Wounds 2007; 6: 254-61.   DOI   ScienceOn
13 Mustoe TA, O'Shaughnessy K, Kloeters O: Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast Reconstr Surg 2006; 117: 35S-41S.
14 Levine B, Kroemer G: Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.   DOI   ScienceOn
15 Mizushima N: Autophagy: process and function. Genes Dev 2007; 21: 2861-73.   DOI   ScienceOn
16 Zongze Z, Jia Z, Chang C, Kai C, Yanlin W: Protective effects of remifentanil on septic mice. Mol Biol Rep 2010; 37: 2803-8.   DOI   ScienceOn
17 Wong GT, Huang Z, Ji S, Irwin MG: Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth 2010; 24: 790-6.   DOI   ScienceOn